Psiconáutica Editorial Team · October 7, 2026 In briefAn open-label pilot study at Johns Hopkins provided two psilocybin sessions to 20 people with persistent symptoms...

Psiconáutica Editorial Team · October 7, 2026 In briefThe Governor of Delaware has signed SB 249, establishing a state licensing system for harm reduction programs.The...

Bouso challenges the term "entheogen," favors "hallucinogen," debunks the myth of the idealized shaman, and reviews his ayahuasca research.

Albert Hofmann recounts the discovery of LSD and his personal friendship with Aldous Huxley, examined through historical context and critical reflection.

Ibogaine is under investigation for opioid addiction. We review the clinical evidence, cardiac risks, and why it remains experimental.

Can smoking toothpaste get you high? Far from being a recreational drug, this habit poses a serious toxicological risk. Eduardo Hidalgo debunks urban legends about toothpaste-induced hallucinations and warns of the dangers of fluoride poisoning, urging readers to prioritize dental health instead.

We explore the clinical profile of ketamine, from its safety in surgery to its emerging role in treatment-resistant depression and addiction.